Table 1.
Summary statistics for full cohort (n = 117), with breakdowns by indolent, significant, and aggressive disease type. Pre-operative radical prostatectomy PSA—Pre-operative PSA, digital rectal examination—DRE, year—Y, Gleason score—GS, Organ confined—OC, None Organ confined—NOC.
| Full Cohort (n = 117) |
Indolent (n = 41) |
Significant (n = 32) |
Aggressive (n = 44) |
|
|---|---|---|---|---|
| Age (y) | ||||
| Mean (median) | 60.6 (60) | 59.1 (59) | 59.9 (59.5) | 62.6 (62.5) |
| Range | 49–74 | 49–70 | 49–73 | 52–74 |
| Pre-Op PSA (ng/mL) | ||||
| Mean (median) | 7.05 (6.5) | 6.5 (6) | 7.11 (6.3) | 7.51 (6.7) |
| Range | 0.7–18.7 | 0.7–12.3 | 2.8–14.7 | 3.1–18.7 |
| Clinical Stage-DRE (%) | ||||
| T1c | 61 (52) | 24 (58) | 19 (59) | 18 (41) |
| T2a | 21 (18) | 4 (10) | 6 (19) | 11 (25) |
| Not described | 35 (30) | 13 (32) | 7 (22) | 15 (34) |
| Biopsy GS (%) | ||||
| ≤6 | 57 (49) | 38 (93) | 11 (34) | 8 (18) |
| 3 + 4 = 7 | 35 (30) | 3 (7) | 16 (50) | 16 (36) |
| 4 + 3 = 7 | 13 (11) | 0 (0) | 4 (13) | 9 (20) |
| ≥8 | 11 (9) | 0 (0) | 1 (3) | 10 (22) |
| Not described | 1 (1) | 0 (0) | 0 (0) | 1 (2) |
| Prostatectomy Stage | ||||
| OC | 73 (62) | 41 (100) | 32 (100) | 0 (0) |
| NOC | 44 (38) | 0 (0) | 0 (0) | 44 (100) |
| Prostatectomy GS (%) | ||||
| ≤6 | 41 (35) | 41 (100) | 0 (0) | 0 (0) |
| 3 + 4 = 7 | 45 (48) | 0 (0) | 27 (84) | 18 (41) |
| 4 + 3 = 7 | 21 (18) | 0 (0) | 2 (6) | 19 (43) |
| ≥8 | 10 (9) | 0 (0) | 3 (10) | 7 (16) |